Mouse slide
Taichu Biology
Innovative Drug Non Clinical
Research and Service Platform (CRO)

Taichu Biology, founded in October 2020, is a contract research organization (CRO) focusing on non clinical research and services of
innovative drugs, located in Life Blue Bay of Shanghai Lingang Special Area.

Business scope
Team experience
The core management team is led by well-known domestic scientists, with over 30 years of experience in pharmacology and toxicology services, strong technical development capabilities, and professional experimental protocol design capabilities
  • 30Many years
    The team has over 30 years of experience in pharmacological and toxicological services
  • 630Many
    Serving over 630 new drug research and development institutions
  • 8000Multiple
    Completed over 8000 services
  • 1200Multiple
    Completed over 1200 new drug efficacy, pharmacokinetics, and safety evaluations
  • 120Multiple
    More than 120 projects have been declared and successfully conducted clinical trials in countries such as the US FDA, the Netherlands, Poland, and Australia.
Project experience
  • Experience in preclinical pharmacodynamics research
    Organ like research:Successfully constructed 14 PDO models, covering major pathological models such as HGSC, EMC, CCC, SBT, etc
    Bone system efficacy test:Models of osteoporosis, osteoarthritis, rheumatoid arthritis, etc
    Screening and evaluation of analgesic drugs:Models of inflammatory pain, neuropathic pain, bone cancer pain, incision pain, etc
    Screening and evaluation of hair care drugs:Models of androgenic alopecia and alopecia areata
    Tumor efficacy test:Liver cancer, lung cancer, kidney cancer, breast cancer, ovarian cancer, gastric cancer, lymphoma, melanoma, glioma and other models
    Cardiovascular and cerebrovascular efficacy test:Ischemic stroke, myocardial ischemia, hypertension, arrhythmia, hyperlipidemia/atherosclerosis and other models
    Neuropsychiatric efficacy test:Alzheimer's disease, Parkinson's disease, epilepsy, spinal cord/brain injury, cerebral vasospasm, depression and other models
    Efficacy test of COVID-19 neutralizing antibody
    RSV neutralizing antibody titer detection test
    Pharmacodynamic studies on mesenchymal stem cells in the treatment of ischemic stroke, ankylosing spondylitis, aGVHD, and other conditions
  • Experience in preclinical toxicology research
    Toxicological evaluation research covering small molecule drugs, antibody drugs, ADC drugs, peptide protein drugs, small nuclear acid drugs, and cell gene therapy products.
Factory facilities
News information
  • Group dynamics
  • Media coverage
  • Technical articles